[Current focus on inflammatory intestinal diseases: Crohn's disease and ulcero-hemorrhagic rectocolitis].
Fontaine
F
F
Centre Hospitalier Saint-Joseph-Espérance, Liège.
Brassinne
A
A
Delforge
M
M
Demoulin
J C
JC
Drèze
C
C
Gillard
V
V
Bastens
B
B
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000008:administration & dosage; D002648:Child; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D005944:Glucosamine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D012460:Sulfasalazine / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D004338:Drug Combinations; D007166:Immunosuppressive Agents; C028423:Salazopyrine; D012460:Sulfasalazine; D005944:Glucosamine
Mise au point actualisée sur les maladies intestinales inflammatoires (MII): maladie de Crohn et recto-colite ulcéro-hémorragique.